Learning outcomes
By the end of this course participants should be able to:
- Understand the evolving concepts of brain tumour biology
- Interpret more complex brain imaging for the purpose of therapy
- Make judgements regarding multidisciplinary management of tumours including the role of systematic and targeted therapies in both common and rare brain tumours in adults and children
- Understand the principles and practice of modern radiotherapy
- Understand the design and challenges of brain tumour clinical trials.
Course content
Neuro-oncology is generally equated with the management of malignant gliomas, yet it is the speciality with perhaps the largest range of tumour types from curable to barely treatable. It has been at the forefront of technical developments in radiotherapy with early implementation of the latest imaging and high precision localised radiotherapy, including stereotactic radiotherapy and proton therapy. Neurosurgery has also developed in leaps and bounds so that previously inaccessible locations can now be safely reached. Local treatment relies on accurate imaging, and this is the cornerstone of neuro-oncology practice.
Alongside local treatment approaches, systemic treatment has become mainstay of management of many tumours in adults and children and targeted personalised therapy approaches are becoming a reality. The need for developing and testing new therapies in this challenging clinical setting requires the involvement of neuro-oncology specialists in clinical trials and the issues specific to brain tumour trial design are of importance to the future of the speciality.
Anyone involved in neuro-oncology is aware of the challenges in treating the brain and the short- and long-term consequences for the patient and their careers, and that attention to care is an integral part of neuro-oncology.
Prerequisites
Before commencing this course, you should have some:
- · Experience of brain tumour management
- · Understanding of conventional brain radiotherapy issues.